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Abstract
The alarming growth of the number of antibiotic resistant bacteria and difficulties in 
treatment of infections have initiated a search for new antibacterial compounds and 
develop new alternative strategies in combating bacterial infections. Plant-derived com-
pounds could exhibit a direct antibacterial activity and/or an indirect activity as antibi-
otic resistance modifying compounds, which, combined with antibiotics, increase their 
effectiveness. This ability of plant active substances reflects in modification or block-
ing of resistance mechanism so that bacterium becomes sensitive to antibiotic or the 
antibiotic acts when in lower concentrations. The systematic screening of plant-derived 
bioactive compounds, including those which can synergistically act with antibiotics, 
as resistance modifying agents represents a potential approach to overcome bacterial 
resistance. Therefore, the goals of this chapter are (i) an update of literature review 
on synergism between plant extracts and antibiotics, (ii) presentation of experimental 
results of synergistic activity of selected plant extracts and antibiotics and (iii) conclud-
ing remarks.
Keywords: antibacterial activity, synergism, antibiotic, plant extract, mode of action
1. Introduction
From the beginning of the antibiotic era, it was noticed that bacteria had the potential to 
develop resistance to antibiotics. Those early treatment failures with antibiotics did not repre-
sent a significant clinical problem because other classes of agents, with different cellular tar-
gets, were available [1]. But, in time, the number of antibiotic resistant bacteria has increased 
and antibiotic resistance has become a global public health threat [2].
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the t rms of the Crea ive
Comm ns Attribution Lic nse (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
The remarkable ability of bacteria to adapt to adverse environmental conditions makes them 
capable of surviving at clinically relevant concentrations of existing antibiotics resulting in 
the selection of resistant strains. The misuse and overuse of antibiotics are accelerating this 
process. An antibiotic, as a selective agent, induces genetic changes of bacteria, contributing 
to development, selection and spreading of resistant strains [3]. This process of acquired resis-
tance is supported by rapid mutation and horizontal transfer of resistance genes. Resistance 
genes (via plasmids, transposons) may be transferred between individuals of the same or 
related bacterial species, between members of commensal or pathogenic microbiota and 
between different environmental habitats, thus spreading the resistance. Even more, there 
is evidence that some clinically relevant resistance genes have environmental origin [4]. The 
final score is the list of multi-drug, health-threatening resistant bacteria: methicillin-resistant 
Staphylococcus aureus (MRSA) and coagulase-negative staphylococci, vancomycin-resistant 
Enterococcus species (VRE), extended-spectrum β-lactamases producing Enterobacteriaceae, 
multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, at present.
The alarming growth of the number of antibiotic resistant bacteria and difficulties in treat-
ment of infections have initiated a search for new antibacterial compounds and develop new 
alternative strategies in combating bacterial infections. Medicinal plants, with their long his-
tory of use in folk medicine for the treatment of infectious diseases, have become a promising 
new source of antibacterial agents. Plant-derived compounds could exhibit a direct antibacte-
rial activity and/or an indirect activity as antibiotic resistance modifying compounds, which, 
combined with antibiotics, increase their effectiveness [5]. The systematic screening of plant-
derived bioactive compounds, including those which can synergistically act with antibiotics, 
as resistance modifying agents represents a potential approach to overcome bacterial resis-
tance. Therefore, the goals of this chapter are: (i) an update of literature review on synergism 
between plant extracts and antibiotics, (ii) presentation of experimental results of synergistic 
activity of selected plant extracts and antibiotics and (iii) concluding remarks.
2. Plant-derived antibacterial compounds
Plants produce a whole series of different compounds, which are not of particular signifi-
cance for primary metabolism, but represent an adaptive ability of a plant to adverse abi-
otic and biotic environmental conditions. They have a remarkable effect to other plants, 
microorganisms and animals from their immediate or wider environment. All these organic 
compounds are defined as biologically active substances and generally represent secondary 
metabolites, given the fact that they occur as an intermediate or end products of second-
ary plant metabolism. Apart from determining unique plant characteristics (color, scent, 
flavor), these compounds also complete the functioning of plant organism, showing both 
biological and pharmacological activities of a plant [6]. They represent a structurally diverse 
group of compounds, classified in three major groups: phenolic compounds (simple phenols, 
phenolic acids, flavonoids, quinones, tannins and coumarins), terpenes and alkaloids. These 
compounds can be isolated from plant material as a solvent extract, an essential oil or a super-
critical extract. Crude extracts represent complex mixtures of compounds (of both secondary 
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and primary metabolites), belonging to different biosynthetic and chemical classes that share 
some general mutual characteristics, such as polarity and/or volatility [7]. Plant extracts have 
long been known to possess broad antimicrobial activity and were frequently studied and 
reviewed [7–13]. Their marked antibacterial activity, classification as GRAS (generally recog-
nized as safe) substances and low risk of bacterial resistance development have made them as 
suitable source for development of novel antibacterial agents.
2.1. Mechanisms of action of plant-derived antibacterial compounds
The antibacterial efficiency of plant compounds depends on several factors: (i) characteristics 
of target microorganism (the type, genus, species, strain), (ii) characteristics of plant material 
(botanical source, composition of the bioactive compounds as well as time of harvesting, stage 
of development or method of extraction) and (iii) chemical properties (hydrophilicity, lipo-
philicity, concentration, pH value). It is widely accepted that plant extracts, because of com-
plex nature, possess multiple mechanisms of action. Plant extracts and their main components 
may exhibit activity by: (i) inhibiting bacterial growth or viability, (ii) targeting bacterial viru-
lence factors or (iii) potentiating effectiveness of antibiotics as resistance modifying agents.
The inhibition of bacterial growth occurs through several mechanisms: disruption of mem-
brane function and structure (including the efflux system), interruption of DNA/RNA synthe-
sis and function, interference with intermediary metabolism and induction of coagulation of 
cytoplasmic constituents [7, 8, 14, 15].
Phenolic compounds, initially, affect cell membrane, as high correlation between toxicity and 
hydrophobicity of different phenolic compounds, changing the permeability and causing the 
leakage of cellular content or interfere with membrane proteins resulting in structure disrupt-
ing [7, 8, 14–16]. Besides the effect on cellular membrane, flavonoids, also, inhibit nucleic 
acid synthesis (caused by topoisomerase inhibition) and energy metabolism (caused by 
NADH-cytochrome c reductase or ATP synthase inhibition) as well as interrupt cell wall and 
cell membrane synthesis [17]. Quinones have a potential to form irreversible complex with 
nucleophilic amino acids in proteins. Probable targets in the microbial cell are surface-exposed 
adhesins, cell wall polypeptides and membrane-bound enzymes [8]. Tannins are subdivided 
into two groups: hydrolysable (gallotannins and ellagitannins) and condensed (proanthocy-
anidins) tannins. Proanthocyanidins possess several mode of action such as destabilization 
of cell membrane, inhibition of extracellular microbial enzymes, direct actions on microbial 
metabolism or deprivation of the substrates required for microbial growth [14]. The activity of 
gallotannins is attributable to their strong affinity for iron, and it is also related to the inactiva-
tion of membrane-bound proteins [18]. Coumarins cause a reduction in cell respiration [8]. 
Terpenes, compounds built up from isoprene subunits, because of lipophilic nature cause cell 
membrane disruption [19]. Alkaloids, one of the earliest isolated bioactive compounds from 
plants, possess ability to intercalate with DNA, interrupt activity of enzymes (esterase, DNA-, 
RNA-polymerase) or cell respiration [19].
Above that plant compounds have impact on growth and viability of bacteria, several research 
papers have discussed the effects of these compounds in modulating various aspects of bacte-
rial virulence. It was observed that plant extracts inhibit bacterial biofilm formation, motility, 
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attachment and cell communication [20–23]. Biofilm formation is additional virulence factor 
that helps in the persistence of pathogens, and bacteria within a biofilm are more resistant to 
host defense and to antibiotics what make difficulties in eradication of infections. Moreover, 
plant extracts and their main compounds are able to suppress bacterial toxin production by 
reducing the expression of major virulence genes. Upadhyay et al. [24] have summarized the 
published results and showed that selected plant extracts inhibit the production of cholera 
toxin by Vibrio cholerae, reduce the production of Staphylococcus aureus 𝛼-hemolysin, entero-
toxins and toxic shock syndrome toxin 1, reduce the production of verotoxin and inactivate 
Shiga toxins.
Finally, numerous investigations have shown that plant extracts in combination with antibi-
otics increase their activity and decrease the doses of antibiotics and their side effects. These 
positive interactions are considered as a potential strategy to combat bacterial resistance. The 
following sections will focus on synergistic activities of plant extracts and antibiotics.
2.2. Synergistic antibacterial activity of plant extracts and antibiotics
Synergistic interaction between two agents, in which one agent enhances the effect of the 
other and together they act more efficiently than as individual agents, motivated many scien-
tists to examine and assess the significance of synergistic acting of plant-derived compounds 
and traditional antibiotics [25, 26]. It is well known that plant extracts possess antibacterial 
properties but, also, the ability to enhance the activity of an antibiotic in combination with 
it. That ability of plant active substances reflects in modification or blocking of resistance 
mechanism so that bacterium becomes sensitive to antibiotic or the antibiotic acts when in 
lower concentrations. Such an approach, besides reducing the effective dose of antibiotics on 
one side, also reduces the side effects of antibiotics as medicine on the other.
Numerous in vitro researches have confirmed synergistic effects of plant extracts and antibi-
otics with a significant reduction of minimum inhibitory concentration (MIC) in antibiotics. 
Scientists have tested various types of extracts of numerous plants in combination with differ-
ent antibiotics. These were primarily antibiotics from the group of inhibitors of cell wall synthe-
sis and protein synthesis. The tests included both Gram-positive and Gram-negative bacteria.
The ethanol extract of Punica granatum rind showed very good synergistic activity with cip-
rofloxacin resulting in upto 34-fold reduction of MIC and re-sensitization of Klebsiella pneu-
moniae resistant strain [27]. The antibacterial and modulatory potential of the ethanol extracts 
obtained from leaves and bark of Azadirachta indica in combination with aminoglycosides and 
carbapenems against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa was 
tested. The association between the ethanol bark extract and amikacin against P. aeruginosa 
PA 24 strain showed synergistic effect. Synergistic effect was also combined with ethanol 
bark extract and imipenem, amikacin or gentamicin against E. coli strains and with imipenem 
against S. aureus strains [28]. Results of combination assay between grape pomace extract and 
antibiotics showed that the extract combined with representatives of different classes of anti-
biotics as β-lactam, quinolone, fluoroquinolone, tetracycline and chloramphenicol acted in 
synergy in all S. aureus and E. coli strains tested with fractional inhibitory concentration index 
(FICI) values varying from 0.031 to 0.155. The MIC of antibiotics was reduced 4- to 75-fold. 
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The most abundant phenolic compounds identified in the extract were quercetin, gallic acid, 
protocatechuic acid and luteolin. It was also shown that combinations of grape pomace extract 
with antibiotics are not toxic for the HeLa cell line at concentrations in which the synergistic 
effect was observed [29]. Different interactions (synergistic, additive and indifference) were 
observed between Thymbra spicata L. extracts and certain antibiotics, including ampicillin, 
cefotaxime, amikacin and ciprofloxacin. The FICI ranged from 0.02 to 1.5 for S. aureus and 0.25 
to 2 for K. pneumoniae strains. The best synergistic capacity appeared with cefotaxime against 
S. aureus strains, and the activity of cefotaxime was increased from 8- to 128-fold [30]. The 
hydroalcoholic extracts obtained from the leaves of Psidium guajava L. and Psidium brownianum 
Mart ex DC synergistically acted with gentamicin, amikacin and ciprofloxacin against E. coli, 
P. aeruginosa and S. aureus [31]. The antibiotic potentiating property of Vangueria madagas-
cariensis (fruit and leaf extracts) against clinical isolates of Acinetobacter spp. was observed. The 
extracts were found to potentiate the activity of chloramphenicol and ciprofloxacin in a ratio 
of 50% extract: 30% antibiotic [32]. Thakur et al. [33, 34] analyzed the synergistic antibacterial 
potential of hydroethanolic extracts of the stem bark of Berberis aristata and Camellia sinensis 
with third-line antibiotics against carbapenem-resistant E. coli. The analysis of Berberis aristata/
antibiotics combinations revealed synergistic behavior (FICI < 1) with colistin, tigecycline and 
amoxicillin/clavulanate potassium, whereas antagonism (FICI > 1) was seen with ertapenem 
and meropenem [33]. Camellia sinensis/antibiotics combinations showed synergism with tige-
cycline, ertapenem, meropenem, colistin and amoxicillin/clavulanate potassium [34]. Active 
substances of water extract of tea (Camellia sinensis) modified the resistance of methicillin-
resistant S. aureus (MRSA) as well as the resistance of β-lactamases-producing S. aureus. The 
extract diluted 40- to 100-fold reduced MIC of methicillin from ≥256 to ≤0.12 μg/ml, whereas 
the extract diluted 40-fold reduced MIC of penicillin up to ≤0.12 μg/ml [35].
Different scientific papers reported results of synergistic antibacterial activity of various 
plant extracts in the presence of different antibiotics, such as oxacillin, tetracycline, nalidixic 
acid, ofloxacin, chloramphenicol, gentamicin, erythromycin, penicillin, ampicillin, kanamy-
cin and ciprofloxacin. Piper betle L. extracts/antibiotics combination indicated additive and 
synergistic effects. The greatest synergy was observed against P. aeruginosa (FICI 0.09) in the 
70% acetone extract—30% chloramphenicol combination. Synergy was also observed against 
S. aureus, Propionibacterium acnes, S. epidermidis and Streptococcus pyogenes [36]. The extracts 
from Beilschmedia acuta leaves and bark and those from the leaves of Newbouldia laevis and 
Polyscias fulva, at their concentration of 1/2 MIC and 1/5 MIC, were enhanced activity of tetra-
cycline, chloramphenicol, ampicillin, kanamycin and ciprofloxacin against multi-drug resis-
tant bacteria [37]. In the case of Juglans regia extract, 10-fold reduction in MICs was observed 
against S. aureus when it used in combination with oxacillin. In this combination, oxacillin was 
able to inhibit MRSA strains at concentration of 0.312 μg/ml, MIC in combination was 64-fold 
lower than the MIC of oxacillin alone and indicated a reversion of methicillin resistance [38]. 
Indigofera suffruticosa, a popular plant used to treat infections, was investigated as modulator of 
antibiotic effectiveness against S. aureus. Acetone extract and erythromycin showed synergistic 
effects (55.56%; FICI values ranged from 0.3 to 0.5), additive effects (0.6 ≤ FICI ≤0.8) in three and 
an indifferent effect in only one (ratio of 1:9, drug: extract; FICI = 1.7). For the chloroform extract 
and erythromycin combinations, both synergistic (0.2 ≤ FICI ≤ 0.4) and additive (0.7 ≤ FICI ≤ 0.9) 
effects were equally found in four ratios and only one ratio gave a non-interaction (1:9, drug: 
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extract; FICI = 1.7). No synergistic effect was seen with ether extracts, but eight ratios resulted 
in additive effects (0.6 ≤ FICI ≤0.9) and one ratio an indifferent (3:7, drug: extract; FICI = 1.2) 
[39]. Ethanol extract of Hyptis martiusii, with concentration of 32 μg/ml, reduced the effective 
concentrations of antibiotics (amikacin, gentamicin, kanamycin, neomycin and tobramycin) 
over 100-fold, where the tested concentrations of antibiotics ranged from 8 to 256 μg/ml, and 
they were reduced upto ≤1 μg/ml [40]. Sub-inhibitory concentrations of water extract of Catha 
edulis (5 mg/ml) enhanced the activity of tetracycline two- to fourfold, against resistant strains 
of periodontal bacteria (Streptococcus sanguis TH-13, S. oralis SH-2 and Fusobacterium nuclea-
tum) [41]. Nostro et al. [42] showed that combinations of propolis and Zingiber officinale with 
clarithromycin intensified controlling of Helicobacter pylori. Sibanda and Okoh [43] detected 
the synergism of acetone extract of Garcinia kola nuts with amoxicillin, ciprofloxacin, tetracy-
cline and chloramphenicol, whereas the ethanol extracts from Aegopodium podagraria L. and 
Torilis anthriscus in combination with streptomycin and chloramphenicol exhibit synergistic 
and additive effects [44, 45]. Synergistic effect was also established between ciprofloxacin and 
chloroform extract of Jatropha elliptica at the level of concentration of 1/8 MIC of antibiotics. It 
was found that the extract contained active substances inhibiting NorA efflux mechanism [46].
In addition to the synergistic effects observed for the plant extracts, in vitro studies reported 
the capacity of pure compounds to potentiate the activity of antibiotics. The carnosic acid, the 
main bioactive compound of Rosmarinus officinalis extracts, was capable of acting synergisti-
cally with gentamicin against S. aureus clinical isolates. In addition, the carnosol, γ-lactone 
derivative of carnosic acid, isolated from a crude extract from Salvia officinalis L. reduced the 
MICs of aminoglycosides in vancomycin-resistant enterococci. Carnosic acid (8 μg/ml) or 
carnosol (16 μg/ml) reduced the MICs of several aminoglycosides in vancomycin-resistant 
Enterococcus faecium and E. faecalis round 8- to 128-fold [47]. Combinations of tetracycline or 
β-lactam antibiotics with baicalein (5,6,7-trihydroxyflavone) exhibit synergistic effects against 
MRSA [48]. Moreover, it has been reported that epigallocatechin gallate is synergistically 
active in combination with β-lactams, tetracycline, oxytetracycline [49, 50]. The geranylated 
flavanones from Paulownia tomentosa fruits showed a promising synergistic potential with 
antibiotics [51]. Curcumin, a flavonoid isolated from the rhizome of a plant, Curcuma longa L., 
markedly reduced the MICs of the antibiotics oxacillin, ampicillin, ciprofloxacin and norfloxa-
cin used against MRSA. The combined activity of curcumin and antibiotics resulted in a 2- to 
128-fold reduction in MIC values [52]. Allicin, antibacterial compound from garlic (Allium 
sativum), potentiated the action of cefazolin (4- to 128-fold) and oxacillin (32- to 64-fold), 
against Staphylococcus sp. and cefoperazone (8- to 16-fold) against P. aeruginosa [53].
2.3. Mechanisms of synergistic antibacterial activity of plant extracts and antibiotics
When a number of scientific researches have confirmed the synergistic activity of plant extracts 
and antibiotics certainly, the next step was to investigate the mechanisms of the synergistic 
action. It is believed that active compounds from plants modify and inhibit the mechanisms 
of acquired resistance in bacterial cell and thus exhibit a synergistic effect with antibiotics 
[54, 55]. The mechanism of synergistic action is explained by: (i) modification of active sites on 
bacterial cell, (ii) inhibition of enzymes, which catalyze degradation or modification of antibi-
otics, (iii) increase of membrane permeability and (iv) inhibition of efflux pumps (Figure 1).
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2.3.1. Modification of active sites on bacterial cell
Modification of active sites is a common mechanism of resistance and may occur for diverse 
classes of antibiotics. Resistance to β-lactam antibiotics is especially present in Gram-positive 
bacteria. β-lactam antibiotics inhibit metabolism of peptidoglycan binding themselves to pen-
icillin-binding proteins (PBPs), which catalyze cross linking of peptidoglycan in mesh struc-
ture. Without the mesh structure, cell wall becomes mechanically weak, which undermines 
integrity of the bacteria cell. Resistance occurs due to reduced affinity of PBPs for antibiotics 
or due to reduced production of these proteins. All the factors modifying structure, activity 
or synthesis of PBPs influence the reduction of resistance. Numerous scientific papers con-
firmed the change in resistance to β-lactam antibiotics through synergistic acting of antibiot-
ics and plant secondary metabolites. Flavonoid baicalin isolated from Scutellaria amoena [56], 
polyphenol corilagin from Arctostaphylos uva-ursi [57], tellimagrandin and rugosin B from 
wild rose (Rosa canina) [58] and epigallocatechin gallate from green tea (Camellia sinensis) [59] 
significantly reduce MIC of β-lactam antibiotics, especially in case of MRSA. Methicillin resis-
tance is due to the expression of an additional penicillin-binding protein (PBP2a), regulated 
by mecA gene, which has a low β-lactams-binding affinity, and it enables cell wall synthe-
sis. Methicillin inhibits the transpeptidational activities of other PBPs, but PBP2a remains 










Figure 1. Mechanisms of synergistic antibacterial activity: (1) modification of the active site, (2) enzymatic degradation 
of antibiotic, (3) increase of membrane permeability and (4) inhibition of efflux pump.
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completely compensate for the other PBPs because cells grown in the presence of methicillin 
exhibit a marked reduction in the degree of cross-linking. However, the limited degree of 
cross-linking is enough to ensure survival of the cell [60].
2.3.2. Enzymatic degradation or modification of antibiotics
Bacterial cell consists of various enzymatic systems, which inactivate antibiotics. It occurs 
through the processes of hydrolysis, replacement of active groups (acetylation, phosphory-
lation glycosylation and adenylation) and processes of oxidation-reduction [61]. One of the 
well-examined groups of enzymes is the group of β-lactamases. β-lactamases (penicillins 
and cephalosporins) are the enzymes from the group of lyases, which destroy the amino 
link of β-lactam ring turning it into inactive form. On grounds of scientific studies, it has 
been showed that active plant compounds may inhibit these enzymes preventing degrada-
tion of antibiotics. For example, it is well known that epigallocatechin gallate from green 
tea in synergistic interactions with antibiotics increases the effect of antibiotics by inhibit-
ing β-lactamases [62, 63]. Stephania suberosa extracts possess multiple mode of action, inhibit 
β-lactamases activity and increase cell membrane permeability against ampicillin-resistant 
S. aureus [64].
2.3.3. Increase of membrane permeability
Cell wall is a first barrier, which antibiotics and other compounds must overcome to achieve 
their targets and demonstrate their inhibitory activity. In Gram-positive bacteria, the cell 
wall is composed of several layers of peptidoglycan, which are mostly permeable to differ-
ent compounds, while in Gram-negative bacteria, the cell wall is complex. It is constructed 
of a single layer of peptidoglycan and a layer of lipoproteins and lipopolysaccharides 
known as outer membrane. The outer membrane is significant barrier for many compounds 
including antibiotics because of several reasons: (i) polysaccharides restrict or completely 
prevent penetration of antibiotics with high molecular weight, (ii) a lipid layer limits pen-
etration of hydrophilic molecules and (iii) porins enable transport of hydrophilic molecules. 
Entrance to the periplasmic space might occur via diffusion through porins or through the 
lipid bilayer by solubilization. After crossing the outer membrane, compounds can be taken 
out from the periplasmic space by the efflux pumps or inactivated by enzymes, before effec-
tively reaching cell membrane. The cell membrane is another barrier, which restricts influx 
of compounds in cytoplasm. Phenolic compounds and terpenes change function and struc-
ture of membrane. They affect membrane permeability mainly due to perturbation of the 
lipid bilayer causing decrease in lipid density in the bilayer. Reduced density of the lip-
ids results in a permeable membrane [65]. Probably, the increased membrane permeability 
resulted in increased level of the antibiotics inside bacterial cells and their better interaction 
with intracellular targets. Hemaiswarya et al. [66] noticed synergistic interactions of eugenol 
from plant Eugenia aromatic with 10 different hydrophobic and hydrophilic antibiotics in 
case of five Gram-negative bacteria. Synergism occurred due to ability of eugenol to increase 
the permeability of cell membrane, and the concentration of 1 mM caused up to 50% of dam-
age of cell membrane.
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2.3.4. Inhibition of efflux pumps
One of the mechanisms of resistance is also utilized for developing efflux pumps by bacteria 
to expel antibiotics from cells. Efflux pumps work through ATP hydrolysis or on grounds 
of difference in concentration of ions. Numerous plant-derived compounds with significant 
activity as inhibitors of efflux pumps were discovered. Primarily, these compounds are active 
against Gram-positive bacteria [67]. For examples, carnosic acid and carnosol, isolated from 
chloroform extract of Rosmarinus officinale, acted as inhibitors of efflux pumps. A 10 μg/ml of 
carnosic acid and carnosol increased by the activity of tetracycline two- to fourfold in case 
of a S. aureus strain that had Tet (K) pump. Active compounds inactivated efflux pump and 
prevented expelling of tetracycline from the cell. Carnosic acid also increased the activity of 
erythromycin eightfold in case of a S. aureus strain that had Msr (A) pump by inhibiting its 
activity [68]. The same authors tested the active substance from herb Lycopus europaeus in 
combination with tetracycline and erythromycin and detected doubled intensity of antibi-
otics activity in case of S. aureus strains that had Tet (K) and Msr (A) pumps [69]. Baicalein 
isolated from the leaves of Thymus vulgaris demonstrated synergy with ciprofloxacin against 
MRSA strains and with gentamicin against vancomycin-resistant enterococci, apparently by 
the inhibition of the NorA efflux pump [70]. Shahverdi et al. [71] discovered that cinnamal-
dehyde, from Cinnamomum zeylanicum bark essential oil, reduced clindamycin resistance in 
Clostridium difficile inhibiting CdeA efflux pump system, the first multidrug efflux transporter, 
which is identified in C. difficile. Recently, Punica granatum extract inhibits efflux pump of 
multidrug resistant K. pneumoniae [27].
3. In vitro testing of antibacterial synergistic activity of selected 
plant extracts and antibiotics
In this study, different combinations of selected plant extracts and commonly used antibiotics 
were tested, emphasizing the potential role of phytocompounds in increasing the effective-
ness of antibiotics. The experiment involved ethanol, ethyl acetate and acetone extracts from 
five plant species: Cychorium intybus L. (Asteraceae), Salvia officinalis L., Clinopodium vulgare 
L. (Lamiaceae), Cytisus nigricans L. and Dorycnium pentaphyllum Vill. (Fabaceae). The plant 
species were selected on the basis of several factors: (i) use in traditional medicine, (ii) phy-
tochemical composition, (iii) known in vitro antibacterial activity and (iv) insufficient data on 
synergistic activity.
3.1. Materials and methods
3.1.1. Plant material
The aerial parts of C. vulgare, D. pentaphyllum and C. nigricans were collected from the differ-
ent regions of Serbia, while S. officinalis (leaves) and M. officinalis (leaves) were supplied from 
the commercial source. Identification and classification of the plant material were performed 
at the Faculty of Science, University of Kragujevac. The voucher specimens are deposited at 
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the Herbarium of the Faculty of Science, University of Kragujevac. The collected plant materi-
als were air-dried under shade at room temperature and then ground into small pieces, which 
were stored into paper bags at room temperature.
3.1.2. Preparation of samples for testing
Dried, ground plant material was extracted by static maceration with ethanol, ethyl acetate 
and acetone for 3 days at room temperature. Every 24 h, 30 g of plant material was soaked 
with 150 ml of solvent (3 × 150 ml). After filtration, the extracts were concentrated using a 
rotary evaporator at 40°C to obtained dry extracts without trace of solvent (duration of sol-
vent evaporation was 20 min for acetone extract, 30 min for ethyl acetate extract and 45 min 
for ethanol extract). The crude plant extracts were stored at −20°C. Before the testing, the 
crude extracts were dissolved in dimethyl sulfoxide (DMSO) and then diluted into nutri-
ent liquid medium to achieve a concentration of 10% DMSO. The concentrations used in the 
experiments were based on the dry weight of the extracts.
Four antibiotics, amoxicillin, cephalexin, gentamicin and chloramphenicol, were used. Stock solu-
tions of antibiotics were prepared in Mueller-Hinton broth. Each extract was combined with two 
antibiotics of different modes of action (cephalexin/gentamicin, amoxicillin/chloramphenicol).
3.1.3. Microorganisms
The following bacteria were used: S. aureus ATCC 25923, E. coli ATCC 25922, P. aeruginosa 
ATCC 27853 and clinical isolate of S. aureus (PMFKg-B30), Bacillus subtilis (PMFKg-B2), 
K. pneumoniae (PMFKg-B26), E. coli (PMFKg-B32), P. aeruginosa (PMFKg-B28) and P. mirabilis 
(PMFKg-B29). All clinical isolates were a generous gift from the Institute of Public Health, 
Kragujevac. Bacteria were stored in microbiological collection at −70°C (Laboratory of 
Microbiology, Faculty of Science, University of Kragujevac).
Bacterial suspension was prepared from overnight cultures by the direct colony method. 
Colonies were taken directly from the plate and suspended into 5 ml of sterile 0.85% saline. The 
turbidity of initial suspension was adjusted comparing with 0.5 Mc Farland standard. When 
adjusted to the turbidity of a 0.5 Mc Farland standard, a suspension of bacteria contains about 
108 colony forming units (CFUs)/ml. Ten-fold dilutions of initial suspension were additionally 
prepared into sterile 0.85% saline to achieve 106 CFU/ml.
3.1.4. Combination assay
Prior to performing the synergy test, the minimum inhibitory concentrations (MICs) of plant 
extracts and antibiotics were determined using microdilution plate method with resazurin 
in Mueller-Hinton broth [72]. Briefly, 96-well microtiter plates were prepared by dispens-
ing 100 μl of Mueller-Hinton broth into each well. A 100 μl from the stock solution of tested 
compound was added into the first row of the plates. Then, twofold serial dilutions were 
performed by transferring 100 μl of solution from one row to another, using a multichan-
nel pipette. The obtained concentration range was from 0.156 to 20 mg/ml for plant extracts 
and from 0.12 to 1000 μg/ml for antibiotics. Ten microlitres of each 106 CFU/ml bacterial 
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suspension was added to appropriate wells. Finally, 10 μl of resazurin solution was added. 
Resazurin is an oxidation-reduction indicator used for the evaluation of microbial growth. It 
is a blue non-fluorescent dye that becomes pink and fluorescent when reduced to resorufin by 
oxidoreductases within viable cells. The inoculated microtiter plates were incubated at 37°C 
for 24 h. MIC was defined as the lowest concentration of the tested compounds that prevented 
resazurin color change from blue to pink.
The combined activity of plant extracts and antibiotics was evaluated by checkerboard method 
[73]. The testing was performed in 96-well microtiter plates using a 6-by-6 well configuration. 
Twofold dilutions of each antibacterial compounds were prepared. First, 100 μl of Mueller-
Hinton broth was added into 36 wells of a 96-well microtiter plate. Then, 50 μl of each dilu-
tions of extract was added horizontally into six rows, and 50 μl of each dilutions of antibiotic 
was added vertically into six columns. The final volume was 200 μl. The final concentration 
range corresponded to 1/32 MIC – MIC. Each well contained unique combination of plant 
extract and antibiotic concentration. Ten microlitres of each 106 CFU/ml bacterial suspension 
and 10 μl of resazurin solution were added. The microtiter plates were incubated for 24 h at 
37°C. The combination of the compounds in which resazurin color change did not appear 
(growth inhibition) is taken as effective MIC for the combination. Each test included growth 
control and sterility control.
In vitro interactions between antimicrobial agents were determined and quantified by calcu-
lating the fractional inhibitory concentration index (FICI) using the following formula:
  FICI =  MICa in combination  _________________
MICa
 +  MICb in combination  _________________
MICb
 (1)
where MICa is MIC of plant extract and MICb is MIC of antibiotics.
Interpretation of the FICI was as follows: FICI ≤ 0.5 synergy; FICI > 0.5–1 additivity; FICI > 1–4 
indifference and FICI > 4 antagonism. The action of antibacterial agents was considered to be:
• Synergistic, if their joint effect was stronger than the sum of effects of the individual agents
• Additive, if their joint effect was equal to the sum of effects of the individual agents
• Indifferent, if their joint effect was equal to the effect of either individual agent
• Antagonistic, if their joint effect was weaker than the sum of effects of the individual agents 
or weaker than the effect of either individual agent [73].
The mean FICI of all combination was used to categorize results as synergy, additivity, indif-
ference and antagonism.
3.1.5. Statistical analysis
Statistical evaluation of the data was performed by Student’s t-test using the SPSS statistical 
software package, version 20 for Windows. The results were considered to be statistically 
significant at p < 0.05. The results of antibacterial activity of plant extracts were statistically 
analyzed.
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3.2. Results and discussion
3.2.1. Antibacterial activity
The antibacterial activity of tested plant extracts was previously evaluated, and results 
were reported in [68]. Intensity of antibacterial activity depended on the species of bacteria, 
plant species and the type of extract. The MIC values were in range from 0.019 to >20 mg/ml 
(Table 1). In general, the significant antibacterial activity was obtained with acetone extract 
from S. officinalis and ethyl acetate and acetone extract from C. intybus. Other tested extracts 
exhibited moderate activity. Statistically significant difference in activity between extracts 
of C. intybus, S. officinalis and C. vulgare was noticed (Table 1). Antibacterial activity of ethyl 
acetate (p = 0.001) and acetone extract (p = 0.002) of C. intybus was statistically higher than 
the activity of ethanol extract. Acetone extract was the most active (p = 0.018). Moreover, the 
activity of acetone extract of S. officinalis was higher than activity of ethanol (p = 0.004) and 
ethyl acetate extract (p = 0.001). Ethyl acetate (p = 0.015) and acetone extract (p = 0.018) of 
C. vulgare acted better than ethanol extract. Between ethyl acetate and acetone extract, no statis-
tically significant difference in activity was noted (p = 0.756). There is no statistically significant 
difference in action between extracts of C. nigicans and D. pentaphyllum (p < 0.05) (Table 1).
The tested bacterial strains showed different level of sensitivity to the antibiotics (Table 2). 
The resistance profile of bacteria was determined according to European Committee on 
Antimicrobial Susceptibility Testing (EUCAST) breakpoints [74]. In relation to chlorampheni-
col and amoxicillin, all clinical isolates were resistant. Gentamicin and cephalexin were active 
against clinical isolates of B. subtilis, S. aureus and E. coli. Isolates of K. pneumoniae, P.  aeruginosa 
and P. mirabilis were resistant to all tested antibiotics.
3.2.2. Synergistic activity of plant extracts and antibiotics
In vitro testing of combined activity of ethanol, ethyl acetate and acetone extracts of five plant 
species (C. intybus, S. officinalis, C. vulgare, C. nigricans and D. pentaphyllum) and four antibiot-
ics (cephalexin, amoxicillin, gentamicin and chloramphenicol) showed three types of interac-
tion: synergism, additivity and indifference in relation to tested strains of bacteria. In general, 
according to obtained results, the following remarks could be made:
• S. officinalis, C. vulgare and C. nigricans acted synergistically with tested antibiotics, while 
C. intybus and D. pentaphyllum showed additive effect.
• The activity of tested antibiotics was increased up to 32-fold depending on the kind of 
extract and type of bacteria.
• The concentrations of tested extracts, corresponding to values ranging from 1/4 MIC to 1/32 
МIC, increased the activity of antibiotics.
• The synergism was observed almost in case of all tested bacteria, with exception of E. coli 
for which there was no synergism observed in any of the combinations considered. For 
other bacteria, this ratio was shown in the following decreasing order: P. mirabilis > 
K. pneumoniae > B. subtilis > P. aeruginosa ATCC 2785 > S. aureus > S. aureus ATCC 25923 > 
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Plant species 1 2 3 4 5 6 7 8 9
MIC (mg/ml)
Cichorium intybus Ea 5 10 10 10 20 20 20 5 2.5
Etb 2.18 2.18 2.18 8.75 8.75 2.18 2.18 2.18 1.09
Acc 2.5 2.5 2.5 5 5 2.5 2.5 2.5 2.5
Salvia officinalis Ea 5 5 5 >20 10 >20 >20 >20 2.5
Eta 10 20 20 >20 >20 >20 >20 >20 2.5
Acb 0.03 0.15 0.31 20 1.25 20 0.31 0.156 0.019
Clinopodium vulgare Ea 1.25 >20 >20 >20 20 >20 20 2.5 20
Etb 0.625 20 10 10 10 10 10 2.5 10
Acb 1.25 20 10 10 10 20 10 0.625 10
Cytisus nigricans Ea 2.5 20 20 10 10 20 20 5 1.25
Eta 5 20 20 20 20 20 20 5 5
Aca 2.5 20 20 10 20 >20 20 2.5 10
Dorycnium pentaphyllum Ea 5 10 20 10 5 20 20 2.5 10
Eta 1.25 20 20 10 10 >20 20 1.25 20
Aca 1.25 20 20 5 5 20 10 1.25 10
1. B. subtilis; 2. K. pneumoniae; 3. S. aureus; 4. P. aeruginosa; 5. P. mirabilis; 6. E. coli; 7. E. coli ATCC 25922; 8. S. aureus ATCC 25923; 9. P. aeruginosa ATCC 27853; E: ethanol 
extract; Et: ethyl acetate extract; Ac: acetone extract; Superscript with different letters are significantly different at p < 0.05, for every plant species separately.
Table 1. Antibacterial activity of tested plant extracts.
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P. aeruginosa > E. coli ATCC 25922. Extracts of Salvia officinalis, together with amoxicillin and 
chloramphenicol, have synergistically acted to most bacteria.
• The ethanol and ethyl acetate extracts of S. officinalis and C. nigricans intensified the ac-
tivity of amoxicillin, gentamicin, cephalexin and chloramphenicol reducing the effective 
concentration by 32-fold against Gram-positive bacteria B. subtilis and S. aureus and Gram-
negative bacteria K. pneumoniae and P. mirabilis.
• The extracts of C. vulgare in combination with cephalexin and gentamicin showed syner-
gistic effect of less intensity. The most active was the combination of acetone extract and 
gentamicin against B. subtilis in which case the MIC of antibiotics was decreased by 16-fold.
• This was the first observation of synergistic effect of C. vulgare and C. nigricans and additive 
effect of C. intybus and D. pentaphyllum with tested antibiotics.
3.2.2.1. Interaction between S. officinalis extracts and antibiotics
The results of combined acting of ethanol, ethyl acetate and acetone extract of S. officinalis and anti-
biotics (chloramphenicol and amoxicillin) expressed in FICI are indicated in Table 3. Synergistic, 
additive and indifferent effects were observed. FICI was ranged in intervals from 0.30 to 1.37.
The extracts showed a better synergistic capacity with amoxicillin than with chlorampheni-
col (Table 4). In reference with initial MIC values, activity of amoxicillin was increased by 
4- to 32-fold depending on the species of bacteria. Of nine tested bacteria, amoxicillin acting 
with ethanol and acetone extract showed synergism against eight bacteria and in case of 
ethyl acetate extract against two bacteria. Only in case of E. coli, there was no synergistic, but 
only indifferent effect observed. On grounds of FICI values, it may be noticed that intensity 
of synergistic effect was different and that extracts of S. officinalis significantly increased the 
activity of amoxicillin (FICI 0.31–0.35) (Table 4).
Bacteria CEF AMO GEN CHL
MIC (μg/ml)
B. subtilis 12.5 31 3.125 250
K. pneumoniae 500 250 6.25 250
S. aureus 1.56 500 0.39 500
E. coli 1.56 >1000 1.56 >1000
P. aeruginosa >1000 >1000 >1000 >1000
P. mirabilis >1000 >1000 >1000 >1000
E. coli ATCC 25922 6.25 6.25 0.39 250
S. aureus ATCC 25923 6.25 1.9 0.19 125
P. aeruginosa ATCC 27853 >1000 0.12 0.098 250
CEF: cephalexin; AMO: amoxicillin; GEN: gentamicin; CHL: chloramphenicol.
Table 2. Antibacterial activity of tested antibiotics.
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Chloramphenicol showed synergism with ethanol and ethyl acetate extract (Table 4). In 
case of combination of chloramphenicol/ethanol extract, synergism was observed against 
four bacteria, while in case of combination of chloramphenicol/ethyl acetate extract, syner-
gism was observed against three bacteria. These combinations reduced the MICs of chlor-
amphenicol even 32-fold in case of mention strains of bacteria. In case of other bacteria, as 
Bacteria Ethanol extract Ethyl acetate extract Acetone extract
CHL AMO CHL AMO CHL AMO
B. subtilis 0.44 (S) 0.32 (S) 0.40 (S) 0.35 (S) 1.37 (I) 0.50 (S)
K. pneumoniae 0.44 (S) 0.32 (S) 0.35 (S) 1.37 (I) 1.37 (I) 0.35 (S)
S. aureus 0.44 (S) 0.39 (S) 0.49 (S) 1.37 (I) 1.37 (I) 0.35 (S)
E. coli 1.37 (I) 1.25 (I) 1.37 (I) 1.37 (I) 1.37 (I) 1.37 (I)
P. aeruginosa 1.37 (I) 0.5 (S) 1.37 (I) 1.37 (I) 1.37 (I) 1.37 (I)
P. mirabilis 1.37 (I) 0.37 (S) 1.37 (I) 0.53 (A) 1.37 (I) 0.49 (S)
E. coli ATCC 25922 0.61 (A) 1.18 (I) 0.61 (A) 0.42 (S) 1.37 (I) 0.38 (S)
S. aureus ATCC 25923 0.61 (A) 0.37 (S) 1.37 (I) 1.37 (I) 1.37 (I) 0.35 (S)
P. aeruginosa ATCC 27853 0.30 (S) 0.31 (S) 0.56 (A) 1.37 (I) 0.61 (A) 0.35 (S)
CHL: chloramphenicol; AMO: amoxicillin.
Table 3. Interaction between S. officinalis extract and antibiotics expressed as FICI.
Bacteria Amoxicillin Chloramphenicol
Ethanol extract Ethyl acetate 
extract
Acetone extract Ethanol extract Ethyl acetate 
extract
МIC*
B. subtilis 1/16E + 1/8A 1/16E + 1/32A 1/4E + 1/4A 1/4E + 1/8A 1/8E + 1/32A
K. pneumoniae 1/8E + 1/16A / 1/32E + 1/16A 1/4E + 1/8A 1/16E + 1/32A
S. aureus 1/4E + 1/16A / 1/32E + 1/16A 1/4E + 1/8A 1/4E + 1/32A
P. aeruginosa 1/4E + 1/4A / / 1/32E + 1/8A /
P. mirabilis 1/32E + 1/4A / 1/32E + 1/4A / /
E. coli
ATCC 25922
/ 1/8E + 1/16A 1/8E + 1/16A / /
S. aureus
ATCC 25923
1/8E + 1/8A / 1/32E + 1/16A / /
P. aeruginosa 
ATCC 27853
1/8E + 1/16A / 1/32E + 1/16A / /
“/” no synergism; E – extract; A – antibiotic.
*The most active combination.
Table 4. Synergism between S. officinalis extracts and antibiotics.
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well as in combination of chloramphenicol/acetone extract, additive and indifferent effects 
were observed. Horiuchi et al. [47] observed that acetone extract of S. officinalis and isolated 
components, carnosol and carnosic acid, increased the activity of aminoglycosides against 
vancomycin-resistant enterococci. These herbal components reduced the MIC of antibiotics 
by 8- to 128-fold depending on the type of bacteria.
3.2.2.2. Interaction between C. vulgare extracts and antibiotics
The results of combined acting of ethanol, ethyl acetate and acetone extract of C. vulgare and 
antibiotics (cephalexin and gentamicin) expressed in FICI are presented in Table 5. Synergistic 
and indifferent effects were observed. FICI was ranged in intervals from 0.39 to 1.67. The etha-
nol extract exhibited the best synergistic capacity with antibiotics.
For most tested bacteria, interactions of extracts and antibiotics were indifferent. Synergism 
was observed against four bacteria: B. subtilis, K. pneumoniaе, P. aeruginosa and P. mirabilis. 
There was a synergistic acting of gentamicin with all three extracts in relation to B. subtilis, 
while cephalexin acted synergistically with ethanol and ethyl acetate extract (Table 6). In 
these combinations, FICI was 0.39 and 0.44. As for K. pneumoniaе, the strain that was resistant 
to cephalexin, the combination of cephalexin with ethanol and acetone extracts showed a syn-
ergism. The concentrations of extracts of 1/4 MIC intensified the activity of cephalexin, and 
MIC was decreased fourfold.
The ethanol extract showed with both tested antibiotics a synergistic activity against P. aeruginosa 
and P. mirabilis. The test results were interesting because the strains showed resistance to cepha-
lexin and gentamicin. In synergistic combinations, it was observed that sub-inhibitory concen-
trations of extracts (1/4 MIC and 1/8 MIC) modified activity of antibiotics by reducing effective 
concentrations of antibiotics up to 16-fold.
Bacteria Ethanol extract Ethyl acetate extract Acetone extract
GEN CEF GEN CEF GEN CEF
B. subtilis 0.44 (S) 0.44 (S) 0.44 (S) 0.44 (S) 0.39 (S) 1.29 (I)
K. pneumoniae 1.33 (I) 0.50 (S) 1.33 (I) 1.67 (I) 1.33 (I) 0.50 (S)
S. aureus 1.04 (I) 1.23 (I) 1.24 (I) 1.23 (I) 1.19 (I) 1.07 (I)
E. coli 1.56 (I) 1.67 (I) 1.67 (I) 1.67 (I) 1.33 (I) 1.67 (I)
P. aeruginosa 0.50 (S) 0.50 (S) 1.33 (I) 1.33 (I) 1.33 (I) 1.33 (I)
P. mirabilis 0.44 (S) 0.50 (S) 1.34 (I) 1.39 (I) 1.34 (I) 1.39 (I)
E. coli ATCC 25922 1.56 (I) 1.45 (I) 1.56 (I) 1.33 (I) 1.35 (I) 1.33 (I)
S. aureus ATCC 25923 1.24 (I) 1.34 (I) 1.12 (I) 1.19 (I) 1.24 (I) 1.19 (I)
P. aeruginosa ATCC 27853 1.19 (I) 1.24 (I) 1.14 (I) 1.24 (I) 1.19 (I) 1.24 (I)
GEN: gentamicin; CEF: cephalexin.
Table 5. Interaction between C. vulgare extracts and antibiotics expressed as FICI.
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3.2.2.3. Interaction between C. nigricans extracts and antibiotics
The results of combined acting of ethanol, ethyl acetate and acetone extract of C. nigricans and 
antibiotics (cephalexin and gentamicin) expressed in FICI are presented in Table 7. Synergistic 
and indifferent effects were observed. FICI was ranged in intervals from 0.30 to 1.56. The etha-
nol extract exhibited the best synergistic capacity with antibiotics.
The ethanol extract synergistically acted with both antibiotics against B. subtilis, K. pneumoniaе 
and P. mirabilis (Table 8). The strain of Proteus mirabilis was resistant to gentamicin and cepha-














B. subtilis 1/8E + 1/4A 1/4E + 1/8A 1/4E + 1/16A 1/8E + 1/4A 1/4E + 1/8A /
K. pneumoniae / / / 1/4E + 1/4A / 1/4E + 1/4A
P. aeruginosa 1/4E + 1/4A / / 1/4E + 1/4A / /
P. mirabilis 1/4E + 1/8A / / 1/4E + 1/4A / /
“/” no synergism; E – extract; A – antibiotic.
*The most active combination.
Table 6. Synergism between C. vulgare extracts and antibiotics.
Bacteria Ethanol extract Ethyl acetate extract Acetone extract
GEN CEF GEN GEN CEF GEN
B. subtilis 0.38 (S) 0.38 (S) 1.29 (I) 1.29 (I) 1.29 (I) 1.29 (I)
K. pneumoniae 0.40 (S) 0.37 (S) 1.47 (I) 1.33 (I) 1.56 (I) 1.33 (I)
S. aureus 1.2 (I) 1.07 (I) 1.27 (I) 1.23 (I) 1.29 (I) 1.23 (I)
E. coli 1.35 (I) 1.44 (I) 1.47 (I) 1.33 (I) 1.56 (I) 1.33 (I)
P. aeruginosa 1.33 (I) 1.33 (I) 1.33 (I) 1.33 (I) 1.33 (I) 1.33 (I)
P. mirabilis 0.30 (S) 0.37 (S) 0.30 (S) 1.07 (I) 0.40 (S) 0.40 (S)
E. coli ATCC 25922 1.41 (I) 1.56 (I) 1.41 (I) 1.56 (I) 1.41 (I) 1.41 (I)
S. aureus ATCC 25923 1.12 (I) 1.24 (I) 1.32 (I) 1.12 (I) 1.42 (I) 1.24 (I)
P. aeruginosa ATCC 27853 0.44 (S) 1.24 (I) 1.12 (I) 1.20 (I) 1.12 (I) 1.24 (I)
GEN: gentamicin; CEF: cephalexin.
Table 7. Interaction between C. nigricans extracts and antibiotics expressed as FICI.
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3.2.2.4. Interaction between C. intybus extracts and antibiotics
The results of combined acting of ethanol, ethyl acetate and acetone extract of C. intybus and 
antibiotics (amoxicillin and chloramphenicol) expressed in FICI are presented in Table 9. 
Additive and indifferent effects were observed. FICI was ranged in intervals from 0.56 to 1.37. 
The results demonstrated that extracts increased activity of amoxicillin better than activity 
of chloramphenicol. The most active combinations were with ethanol extract in relation to 
B. subtilis and P. mirabilis. For these combinations, additive effects were observed, and MICs 
of antibiotics decreased twofold. On the other side, Ahmad and Aquil [75] noticed synergism 
between ethanol extract and tetracycline, chloramphenicol and ciprofloxacin.
Bacteria Gentamicin Cephalexin
Ethanol extract Ethyl acetate 
extract
Acetone extract Ethanol extract Acetone extract
МIC*
B. subtilis 1/8E + 1/8A / / 1/8E + 1/8A /
K. pneumoniae 1/4E + 1/16A / / 1/32E + 1/4A /
P. mirabilis 1/8E + 1/32A 1/8E + 1/32A 1/16E + 1/4A 1/4E + 1/32A 1/4E + 1/16A
P. aeruginosa
ATCC 27853
1/4E + 1/8A / / / /
“/” no synergism; E – extract; A – antibiotic.
*The most active combination.
Table 8. Synergism between C. nigricans extracts and antibiotics.
Bacteria Ethanol extract Ethyl acetate extract Acetone extract
CHL АMO CHL АMO CHL АMO
B. subtilis 0.56 (A) 0.61 (A) 1.37 (I) 1.37 (I) 0.91 (A) 0.86 (A)
K. pneumoniae 0.68 (A) 0.68 (A) 1.37 (I) 0.84 (A) 0.91 (A) 0.68 (A)
S. aureus 1.29 (I) 0.7 (A) 1.37 (I) 0.62 (A) 0.74 (A) 0.59 (A)
E. coli 1.37 (I) 1.37 (I) 1.37 (I) 0.7 (A) 1.37 (I) 0.7 (A)
P. aeruginosa 1.37 (I) 1.37 (I) 1.37 (I) 1.37 (I) 1.37 (I) 1.37 (I)
P. mirabilis 1.37 (I) 0.56 (A) 1.37 (I) 0.7 (A) 1.37 (I) 0.67 (A)
E. coli ATCC 25922 1.37 (I) 1.37 (I) 1.37 (I) 1.37 (I) 1.37 (I) 0.87 (A)
S. aureus ATCC 25923 1.37 (I) 0.7 (A) 1.37 (I) 1.37 (I) 1.37 (I) 1.37 (I)
P. aeruginosa
ATCC 27853
1.37 (I) 1.37 (I) 1.37 (I) 1.37 (I) 1.37 (I) 1.37 (I)
CHL: chloramphenicol; AMO: amoxicillin.
Table 9. Interaction between C. intybus extracts and antibiotics expressed as FICI.
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3.2.2.5. Interaction between D. pentaphyllum extracts and antibiotics
The results of combined acting of ethanol, ethyl acetate and acetone extract of D.  pentaphyllum 
and antibiotics (cephalexin and gentamicin) expressed in FICI are presented in Table 10. 
Additive and indifferent effects were observed. FICI was ranged from 0.56 to 2.0. The etha-
nol extract indifferently acted with antibiotics. Additive effect was noticed in combination 
with ethyl acetate and acetone extract. In these combinations, MIC values of antibiotics were 
decreased two times in presence of 1/4 MIC of extracts.
4. Concluding remarks
The problem of bacterial resistance is growing, and the outlook for the use of antibacterial 
drugs in the future is still uncertain. Even though pharmacological industries have produced 
a number of new antibiotics in the last few decades, resistance to these drugs by bacteria has 
increased. Plants are valuable sources of new and biologically active molecules possessing 
antibacterial properties. This activity can be attributable both to direct action against bacte-
ria or as synergistic activity with antibiotics. The in vitro synergistic activity of plant active 
compounds against multidrug-resistant bacteria has been widely shown by the numerous 
scientific studies. This progress in synergy research enhances the possibility of designing new 
antibacterial agents of plant origin for the treatment of infections. However, the mechanisms 
underlying these synergy effects are still poorly explored. Only with exact knowledge of these 
mechanisms, it will be possible to develop a new generation of standardized, effective prepa-
rations. Furthermore, in vivo testing of activity, toxicity and bioavailability will determine 
Bacteria Ethanol extract Ethyl acetate extract Acetone extract
GEN CEF GEN CEF GEN CEF
B. subtilis 1.13 (I) 1.29 (I) 1.031 (I) 1.24 (I) 1.29 (I) 0.56 (A)
K. pneumoniae 1.30 (I) 1.33 (I) 0.75 (A) 1.37 (I) 1.24 (I) 1.30 (I)
S. aureus 1.29 (I) 1.23 (I) 0.56 (A) 1.12 (I) 1.07 (I) 1.18 (I)
E. coli 1.56 (I) 1.75 (I) 2.00 (I) 1.67 (I) 1.67 (I) 1.33 (I)
P. aeruginosa 1.33 (I) 1.33 (I) 1.031 (I) 1.34 (I) 1.37 (I) 1.37 (I)
P. mirabilis 1.17 (I) 1.07 (I) 0.84 (A) 1.37 (I) 0.68 (A) 0.91 (A)
E. coli ATCC 25922 1.18 (I) 1.30 (I) 0.63 (A) 1.33 (I) 1.33 (I) 1.35 (I)
S. aureus ATCC 25923 1.07 (I) 1.12 (I) 0.75 (A) 1.33 (I) 1.19 (I) 1.24 (I)
P. aeruginosa
ATCC 27853
1.12 (I) 1.20 (I) 1.25 (I) 1.33 (I) 1.37 (I) 1.19 (I)
GEN: gentamicin; CEF: cephalexin.
Table 10. Interaction between D. pentaphyllum extracts and antibiotics expressed as FICI.
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their actual relevance for treatment of human infection diseases. Finally, an excellent database 
of active compounds is formed, and future studies on bioavailability, pharmacodynamics and 
mechanism of action will contribute in the development of new antibacterial agents.
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